European Leukemia Trial Registry
Trial: GMALL-PH-01

More Details
Title Study of standard induction and consolidation therapy in combination with dasatinib in Ph+ ALL
Scientific Title Open label phase II study to evaluate the safety of standard induction and consolidation therapy in combination with dasatinib in newly diagnosed adult patients with philadelphia chromosome positive Acute Lymphoblastic Leukemia (Ph+ALL)
Short Title GMALL-PH-01
Trialgroup GMALL
Disease Acute lymphoblastic leukemia(ALL) Ph/BCR ABL +
Age <= 55 years
Status Closed
Start of Recruitment 15.04.2011
Leader Ottmann, Prof. Dr., Oliver
Contactperson

Study Centre
Gökbuget, Dr. med., Nicola
Tel: +49 (0)69 6301-6366
Fax: +49 (0)69 6301- 7463
Email: goekbuget@em.uni-frankfurt.de

Centre of Trial Universitätsklinikum Frankfurt
Shortprotocol Shortprotocol
created 02.03.2011 Roswitha Kotthoff
changed 03.05.2018 Student Studienregister
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org